News

Toys ‘R’ Us unveils must-have toys for the holidays

BY Allison Cerra

WAYNE, N.J. Toys “R” Us on Tuesday released its 2010 Holiday Hot Toy List, featuring items from such toy titans as Fisher-Price, Hasbro and Mattel.

The top 15 toys that should be on everyone’s wish list this year include Cuponk and Nerf N-Strike Stampede ECS from Hasbro; Imaginext Bigfoot the Monster and Disney-Pixar “Toy Story 3” Imaginext Tri-County Landfill from Fisher-Price; and Loopz, Monster High, Cleo DeNile and Deuce Gorgon doll set, as well as Sing-a-ma-jigs! from Mattel.

“The Toys ‘R’ Us merchant team has shopped the world to create a list of the 36 top toys guaranteed to delight kids of every age this Christmas season,” said Karen Dodge, SVP and chief merchandising officer for Toys “R” Us U.S. “Each of the items on the 2010 Toys ‘R’ Us Holiday Hot Toy List represents a combination of quality and value, offering children toys they can enjoy for years to come, while providing parents with a selection of products at a variety of price points that can fit any budget.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Genentech amends approval application for expanded use of Avastin

BY Alaric DeArment

SOUTH SAN FRANCISCO, Calif. Biotech company Genentech has amended its application to the Food and Drug Administration seeking an additional approval for one of its drugs, which the FDA has deemed a “major amendment,” Genentech said Monday.

 

Genentech, part of Swiss drug maker Roche, is seeking approval for Avastin (bevacizumab) combined with paclitaxel chemotherapy for untreated advanced breast cancer without the HER2 protein. The FDA has granted accelerated approval to Genentech’s application, and the company expects the agency to take action by Dec. 17. The expected action date is based on the FDA’s decision to extend its review period in light of the amendment.

 

 

“We are pleased by the FDA’s decision to review additional information on Avastin and are committed to working with the agency during this extended review period,” Genentech EVP product development and chief medical officer Hal Barron said.

 

 

Avastin already is approved for treating cancers of the colon and rectum, lungs and kidneys.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Kroger commences Giving Hope a Hand campaign for breast cancer

BY Allison Cerra

CINCINNATI Kroger’s family of stores will showcase breast cancer survivors in its annual Giving Hope a Hand campaign to support breast cancer initiatives in communities across the country.

This year, 56 women share their stories of survival on marketing materials and custom packages of national and Kroger brand items, which will be sold exclusively in Kroger’s family of stores. Kroger’s campaign includes a storewide sales promotion of popular items, many of which will feature exclusive, specially marked pink packaging. This year, 1,800 items, including Kroger’s own products and popular items from such Kroger partners as Pepsi, Kellogg, Kraft, General Mills, Procter & Gamble and Kimberly Clark will be marked with special pink shelf tags to highlight their participation.

“All of us at Kroger applaud these terrific associates for choosing to share their personal stories of fighting breast cancer with our customers and associates,” said David Dillon, Kroger’s chairman and CEO. “We are pleased to have our great people featured in our annual campaign, as they inspire others to take care of themselves and each other.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?